Staff

TOP 5 publications:

1. Weinbrenner A, Peus V, Inta D, Englisch S, Zink M. Risperidone-associated increase in triglyceride levels. Am J Psychiatry. 2009 166(1):113-4.
2. Zink M, Englisch S. Schizophrenia treatment: an obstacle course. Lancet Psychiatry. 2016 3(4):310-12. Epub 2016 Feb 24.
3. Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M. Stable Cognitive Deficits in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: A 12-Month Longitudinal Study. Schizophr Bull. 2013 39(6):1261-71. Epub 2012 Oct 27.
4. Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011 41(11):2361-73.
5. Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Juckel G, Krueger-Oezguerdal S, Wobrock T, Hasan A, Riedel M, Müller H, Klosterkötter J, Bechdolf A. Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function. Acta Psychiatr Scand. 2014 130(3):214-26. Epub 2014 Feb 26.